Pegfilgrastim biosimilar (Pfenex)

非格司亭生物类似药 (Pfenex)

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegfilgrastim biosimilar (Pfenex)
Drug Alias Name非格司亭生物仿制药 (Pfenex)培非格司亭生物仿制药 (Pfenex)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfenex Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeutropenia

Other Information

ATC CodeL03AA13
Related LinksN/A